dc.contributor.author | Labuhn, Maurice | |
dc.contributor.author | Adams, Felix F. | |
dc.contributor.author | Ng, Michelle | |
dc.contributor.author | Knoess, Sabine | |
dc.contributor.author | Schambach, Axel | |
dc.contributor.author | Charpentier, Emmanuelle M. | |
dc.contributor.author | Schwarzer, Adrian | |
dc.contributor.author | Mateo Cerdán, Juan Luis | |
dc.contributor.author | Klusmann, Jean Henning | |
dc.contributor.author | Heckl, Dirk | |
dc.date.accessioned | 2018-06-07T08:57:02Z | |
dc.date.available | 2018-06-07T08:57:02Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Nucleic Acids Research, 46(3), p. 1375-1385 (2018); doi:10.1093/nar/gkx1268 | |
dc.identifier.issn | 0305-1048 | |
dc.identifier.uri | http://hdl.handle.net/10651/47259 | |
dc.description.sponsorship | German Cancer Aid [111743 to D.H.]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [714226 to J.H.K.]; DFG [HE-7482/1-1 to D.H.]; DFG [KL-2374/2-1 to J.H.K.]; Cluster of Excellence REBIRTH and SFB738 (DFG) (to F.F.A., A.Scha. and A.Schw.); Hannover Biomedical Research School (to M.L., M.N.). Funding for open access charge: DFG [HE-7482/1-1]. | |
dc.format.extent | p. 1375-1385 | |
dc.language.iso | eng | |
dc.relation.ispartof | Nucleic Acids Research, 46 | |
dc.rights | © 2017 Maurice Labuhn et al. | |
dc.rights | CC Reconocimiento - No Comercial 4.0 Internacional | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
dc.source | Scopus | |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044625711&doi=10.1093%2fnar%2fgkx1268&partnerID=40&md5=128276fd41ac9901292f45ce3cf4b8d5 | |
dc.title | Refined sgRNA efficacy prediction improves large and small-scale CRISPR-Cas9 applications | |
dc.type | journal article | |
dc.identifier.doi | 10.1093/nar/gkx1268 | |
dc.relation.projectID | ERC/Horizon 2020/714226 | |
dc.relation.publisherversion | http://dx.doi.org/10.1093/nar/gkx1268 | |
dc.rights.accessRights | open access | |